As previously reported, tumor localization influences immune response, and CRC patient prognosis [83], and the expression of IL-33 increased in left-sided CRC patients in comparison with right-sided ones, reaching even higher levels in CRC with lymph node (LN) metastasis [84]. This evidence concerns the gene IL33 and colorectal carcinoma.